Influence of the cholinesterase inhibitor galanthamine hydrobromide on normal sleep
- 31 March 1994
- journal article
- clinical trial
- Published by Elsevier in Psychiatry Research
- Vol. 51 (3) , 253-267
- https://doi.org/10.1016/0165-1781(94)90013-2
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- The sleep structure of patients with anxiety disorders in comparison to that of healthy controls and depressive patients under baseline conditions and after cholinergic stimulationJournal of Affective Disorders, 1992
- Pharmacokinetics of Galanthamine Hydrobromide after Single Subcutaneous and Oral Dosage in HumansPharmacology, 1989
- On the contribution of sleep wake physiology to the explanation and the treatment of depressionActa Psychiatrica Scandinavica, 1988
- The Treatment of Mania with the Cholinomimetic Drug RS 86Pharmacopsychiatry, 1986
- Experimental acceleration and slowing of REM sleep ultradian rhythm by cholinergic agonist and antagonistNature, 1978
- The time-dependent induction of REM sleep and arousal by physostigmine infusion during normal human sleepBrain Research, 1977
- REM Sleep Induction by Physostigmine Infusion During SleepScience, 1976
- Sleep Cycle Oscillation: Reciprocal Discharge by Two Brainstem Neuronal GroupsScience, 1975
- Galanthamine hydrobromide versus neostigmineAnaesthesia, 1974
- A CHOLINERGIC-ADRENERGIC HYPOTHESIS OF MANIA AND DEPRESSIONThe Lancet, 1972